Search results
CPET and Exercise Prescription for Cardiac Rehabilitation
Author(s):
Kaoutar Kabbadj
,
Nora Taiek
,
Wiame El Hjouji
,
et al
Added:
1 year ago
Review Article
Author(s):
Gregory Lewis
Added:
4 months ago
HFSA 25 - Aficamten improves excercise capacity compared to metoprolol in patients with obstructive hypertrophic cardiomyopathy in a prespecified analysis of the MAPLE-HCM study.Dr Gregory Lewis joins us to discuss findings from a prespecified cardiopulmonary exercise testing analysis of the MAPLE-HCM trial, which reveals divergent effects between aficamten and metoprolol on exercise performance…
View more
Jamie M O’Driscoll
Job title: Reader in Cardiovascular Physiology
Author
Exploring Exercise-induced Long QT
Author(s):
William Wiradinata
,
Anita Dominique Subali
,
Muhammad Reva Aditya
Added:
6 months ago
Review Article
Author(s):
Mikhail Kosiborod
Added:
1 year ago
HFSA 24 - We are joined virtually by Dr Mikhail Kosiborod (Saint Luke’s Mid America Heart Institute, US) to discuss findings from the STEP-HFpEF trial programme in regard to the efficacy of semaglutide according to frailty status, and exercise function at baseline.Interview Questions:1. Could you remind us of the importance of STEP-HFpEF2. What was the study design and patient population?3. What…
View more
Author(s):
Pam Taub
,
Nikolaus Marx
Added:
1 year ago
RP-UN-CAR-GB-0166 / June 2024This programme features a compelling discussion between two distinguished experts, Prof Pam Taub (University of California, San Diego, US) and Prof Nikolaus Marx (University Hospital RWTH, Aachen, DE), chairperson responsible for the most recent ESC Guidelines for the Management of Cardiovascular Disease in Patients with Diabetes. Together, they delve into a critical…
View more
eCPR: Life-saving or Resource Wasting?
Author(s):
Andrea Elliott
,
Sean van Diepen
,
Steven M Hollenberg
,
et al
Added:
1 year ago
Point-Counterpoint
Author(s):
Oliver Mithoefer
,
Jacob Read
,
Carson Keck
,
et al
Added:
2 years ago
Author(s):
John Dodson
,
Harriette Van Spall
Added:
3 months ago
AHA Scientific Sessions 2025 — Late-breaker host Dr Harriette Van Spall (McMaster University, Hamilton, CA) is joined by BETTER-BP Principal Investigator Dr John Dodson (NYU Langone Health, New York, US) to present the findings of this AHA late-breaking trial (NCT04114669).The BETTER-BP (Behavioral Economics Trial to Enhance Regulation of Blood Pressure) is a phase II pragmatic randomized…
View more
Added:
8 months ago
US Cardiology Review 2025;19:e14.
View more